thrombocytopenia

Novartis scores 3rd phase 3 win for ianalumab this week

A day after posting a pair of phase 3 wins for Sjögren's syndrome, Novartis unveiled a late-stage victory in another B-cell-driven autoimmune disease.

James Waldron Aug 12, 2025 5:09am

Nuvectis axes ovarian cancer program after seeing phase 1b data

Jul 31, 2025 9:15am

Sanofi eyes broad portfolio for rilzabrutinib in immunology

Apr 23, 2021 10:00am

Sanofi snags speedy review for Principia BTK drug, Pompe program

Nov 18, 2020 10:34am

Argenx boosts pipeline with new version of lead drug

Jun 14, 2018 10:50am

Small cap Rigel drops on PhIII failure for lead fostamatinib

Oct 20, 2016 9:42am